Wallace A, Altamura S, Toniatti C, Vitelli A, Bianchi E, Delmastro P, Ciliberto G, Pessi A
Istituto di Richerche di Biologia Molecolare P. Angeletti, Pomezia, Roma, Italy.
Pept Res. 1994 Jan-Feb;7(1):27-31.
We describe here a novel type of synthetic peptide library, named Multimeric Synthetic Peptide Combinatorial Library (M-SPCL), where multiple small peptide ligands are tied together in the same molecule. The advantage of using small peptides in the form of M-SPCL is two-fold: first, the high density assembly of the sequences on the branching scaffold leads to signal amplification, thereby effectively lowering the binding threshold for the selection of ligands; second, to interfere with protein-protein interactions, multimericity has been shown to be a desirable feature per se. The M-SPCL is prepared by solid-phase peptide synthesis, based on the structure of Multiple Antigen Peptides. When prepared in Positional Scanning format [C. Pinilla, J. Appel, P. Blanc and R.A. Houghten. 1992. BioTechniques 13: 901-905], selection is based on the amplified interaction of a single residue in a sequence-defined position. The usefulness of the new library was demonstrated by the selection of octameric peptides, which inhibit the binding of the cytokine human interleukin-6 to its receptor, with an apparent nanomolar affinity. Tetrameric, but not dimeric, branched peptides with the same sequences were also active with comparable affinity. The success of this approach is noteworthy, since screening of the corresponding monomeric pentapeptide SPCL did not lead to the selection of any inhibitory compound in the same system.
我们在此描述一种新型的合成肽库,名为多聚体合成肽组合库(M-SPCL),其中多个小肽配体在同一分子中连接在一起。以M-SPCL形式使用小肽的优势有两方面:其一,序列在分支支架上的高密度组装导致信号放大,从而有效降低配体选择的结合阈值;其二,对于干扰蛋白质-蛋白质相互作用而言,多聚性本身已被证明是一个理想特性。M-SPCL基于多抗原肽的结构通过固相肽合成制备。当以位置扫描形式制备时[C. 皮尼利亚、J. 阿佩尔、P. 布兰克和R.A. 霍顿。1992年。《生物技术》13:901 - 905],选择基于序列定义位置中单个残基的放大相互作用。通过筛选抑制细胞因子人白细胞介素-6与其受体结合的八聚体肽证明了新库的实用性,其表观亲和力为纳摩尔级别。具有相同序列的四聚体而非二聚体分支肽也具有相当的亲和力且有活性。这种方法的成功值得关注,因为在同一系统中筛选相应的单体五肽SPCL未导致选择出任何抑制性化合物。